| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.75B | 17.28B | 18.50B | 22.75B | 18.04B | 13.29B |
| Gross Profit | 3.66B | 4.10B | 4.44B | 5.44B | 4.91B | 3.35B |
| EBITDA | 961.82M | 1.32B | 1.59B | 2.27B | 2.26B | 1.20B |
| Net Income | -197.79M | 172.59M | 498.44M | 906.71M | 563.75M | 126.69M |
Balance Sheet | ||||||
| Total Assets | 27.74B | 26.66B | 26.43B | 25.69B | 22.35B | 19.99B |
| Cash, Cash Equivalents and Short-Term Investments | 3.42B | 3.29B | 3.26B | 4.01B | 2.90B | 2.16B |
| Total Debt | 8.65B | 7.55B | 6.58B | 5.50B | 4.00B | 4.54B |
| Total Liabilities | 16.45B | 15.07B | 14.73B | 14.96B | 12.55B | 10.69B |
| Stockholders Equity | 11.12B | 11.39B | 11.51B | 10.52B | 9.61B | 9.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -429.10M | -968.36M | -68.92M | 1.44B | -369.54M |
| Operating Cash Flow | 0.00 | 1.23B | 427.82M | 1.35B | 2.15B | 531.23M |
| Investing Cash Flow | 0.00 | -1.62B | -1.31B | -1.43B | -716.43M | -900.72M |
| Financing Cash Flow | 0.00 | 444.32M | 214.68M | 1.15B | -748.14M | 328.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥256.03B | 24.11 | ― | 1.17% | 29.51% | 48.81% | |
74 Outperform | ¥85.08B | 7.58 | ― | 3.85% | 9.38% | 8.88% | |
72 Outperform | ¥235.48B | 13.29 | 7.86% | 2.55% | 0.57% | 4.54% | |
67 Neutral | ¥63.79B | 11.27 | ― | 2.82% | 8.75% | 177.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥5.74B | -14.04 | ― | 2.05% | -6.69% | -80.28% | |
62 Neutral | ¥111.43B | 17.03 | 2.64% | 2.30% | -4.11% | 46.76% |